Evidence-based clinical practice guidelines for irritable bowel syndromeShin Fukudo, Tooru Shimosegawa, Toshimi Chiba et al.|Journal of Gastroenterology|2014Cited by 220
Bezafibrate Improves GLOBE and UK‐PBC Scores and Long‐Term Outcomes in Patients With Primary Biliary CholangitisAkira Honda, Atsushi Tanaka, Tetsuji Kaneko et al.|Hepatology|2019Cited by 119
Analysis of 307 cases with drug‐induced liver injury between 2010 and 2018 in JapanMitsuhiko Aiso, Naoya Sakamoto, Hajime Takikawa et al.|Hepatology Research|2018Cited by 61
Environmental factors, medical and family history, and comorbidities associated with primary biliary cholangitis in Japan: a multicenter case–control studyKosuke Matsumoto, Atsushi Tanaka, Satoko Ohfuji et al.|Journal of Gastroenterology|2021Cited by 34
A validation study of the Ursodeoxycholic Acid Response Score in Japanese patients with primary biliary cholangitisMinami Yagi, Kosuke Matsumoto, Atsumasa Komori et al.|Liver International|2020Cited by 21